Farallon Capital Management, L.L.C. / BEAM
Farallon Capital Management, L.L.C.’s Beam Therapeutics Inc Position
Does Farallon Capital Management, L.L.C. own Beam Therapeutics Inc (BEAM)? Yes — 10.13M shares worth $242M (+1.31% of its 13F portfolio) as of Q1 2026, up from 10.06M shares the prior filed quarter.
Position Value
$242M
Q1 2026
Shares
10.13M
% of Portfolio
+1.31%
Quarters Held
22
currently held
Position History BEAM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 10.13M | $242M | +1.31% |
| Q4 2025 | 10.06M | $279M | +1.32% |
| Q3 2025 | 10.06M | $244M | +1.00% |
| Q2 2025 | 10.01M | $170M | +0.72% |
| Q1 2025 | 9.93M | $194M | +1.04% |
| Q4 2024 | 8.24M | $204M | +1.04% |
| Q3 2024 | 8.21M | $201M | +0.98% |
| Q2 2024 | 7.91M | $185M | +0.87% |
| Q1 2024 | 4.51M | $149M | +0.68% |
| Q4 2023 | 4.11M | $112M | +0.49% |
| Q3 2023 | 4.48M | $108M | +0.46% |
| Q2 2023 | 3.44M | $110M | +0.61% |
| Q1 2023 | 3.43M | $105M | +0.52% |
| Q4 2022 | 3.40M | $133M | +0.87% |
| Q3 2022 | 3.63M | $173M | +0.95% |
| Q2 2022 | 3.47M | $134M | +0.76% |
| Q1 2022 | 2.59M | $149M | +0.65% |
| Q4 2021 | 2.27M | $181M | +0.94% |
| Q3 2021 | 1.72M | $149M | +0.72% |
| Q2 2021 | 1.50M | $193M | +0.79% |
| Q1 2021 | 592.5K | $47M | +0.26% |
| Q1 2020 | 170.2K | $3M | +0.02% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farallon Capital Management, L.L.C.’s full portfolio or all institutional holders of BEAM.